SuperworthBabcock & Wilcox Enterprises BW
- Market cap
- $618.2M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/m
- one or more of the four quarters through 2026-06-30 missing
- EV/EBIT
- n/m
- a quarter missing
- Revenue, 12 months
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Net margin
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Free cash flow yield
- −9.4%
Babcock & Wilcox Enterprises' trailing earnings are negative, so it has no PE.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $239.4M+13% | $227.2M−9% | $164.3M−32% | $151.4M−48% | $152.6M−36% | $66.3M−71% | $148.6M−10% | $138.9M−8% | $149M−2% | n/a | $214.4M+44% | $319.7M+130% | |
| Cost of revenue | $186M+13% | $171.6M−11% | $125.5M−34% | $118.3M−48% | $116.5M−37% | $42M−76% | $120.8M−4% | $97.4M−18% | $111.9M−4% | n/a | $171M+42% | $273.1M+180% |
| Gross profit | $53.4M+13% | $55.6M−4% | $38.8M−25% | $33.1M−48% | $36.1M−32% | $24.2M−56% | $27.8M−28% | $41.5M+25% | $37.1M+3% | n/a | $43.5M+57% | $46.6M+13% |
| R&D | $898K−10% | $5.3M+456% | $815K−38% | $890K−4% | $1.2M+35% | $2.1M−60% | $348K−57% | $942K+6% | $303K−75% | n/a | $803K+131% | $619K−34% |
| SG&A | $45.7M−4% | $6.7M−87% | $32.2M−33% | $36.6M−26% | $33.3M−27% | $6.4M−5% | $28.3M−12% | $33.3M−9% | $29.8M−11% | n/a | $44.4M+57% | $33.7M+1% |
| $5.5M | $669K−89% | $5.7M+345% | −$4.4M | $1.6M−72% | −$20M | −$1.8M | $7M | $6.5M+315% | n/a | −$1.7M−10% | $11.8M+68% | |
| Interest expense | $13.4M+21% | $12.6M+4% | $12M−5% | $12M+7% | $10.1M−25% | $10.2M−20% | $11M−8% | $11M−8% | $8.5M−16% | n/a | $4.4M−60% | $5M−54% |
| Pre-tax income | −$12.6M+61% | −$47.8M | −$11.9M−3% | −$15.9M | −$8.4M−33% | −$65.3M+37% | −$13.7M+15% | −$3.4M−79% | −$1.3M−84% | n/a | −$75.5M+451% | $13.2M |
| −$331K | $6.5M+3% | $907K+85% | $4.7M+151% | −$508K+54% | $6M−7% | $1.9M+112% | $4M−14% | $1M | n/a | $4.2M+116% | −$1.1M | |
| Net income | −$116.9M+558% | −$62.7M | −$16.8M+35% | $25.4M | −$5.3M−95% | −$63.2M+1% | −$22M+31% | −$58.5M | $35.1M | $9.2M | −$76.9M+250% | $14.3M |
| −$1.35+463% | −$0.74 | −$0.23+28% | $0.24 | −$0.10−93% | −$0.71−4% | −$0.26+13% | −$0.63 | $0.30 | $0.05 | −$0.60+131% | $0.07 | |
| 89.1M+1% | 89.4M+1% | 89.5M+1% | 91.2M+3% | 92.3M+4% | 94.1M+5% | 97.9M+9% | 98.7M+8% | 103M+12% | 121.8M+29% | 133.8M+37% | 154.5M+57% |
Revenue: Q1 FY14 and Q1 FY15: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY14 and Q1 FY15: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY14 and Q1 FY15: 6 months less the 3 months printed beside them. 47 periods, Q2 FY14 to Q2 FY26: not printed by the filing, worked out from its own lines.
R&D: Q1 FY14 and Q1 FY15: 6 months less the 3 months printed beside them.
SG&A: Q1 FY14: 6 months less the 3 months printed beside them.
Operating income: Q1 FY14 and Q1 FY15: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY14 and Q1 FY15: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY14 and Q1 FY15: 6 months less the 3 months printed beside them.
Income tax: Q1 FY14 and Q1 FY15: 6 months less the 3 months printed beside them.
Net income: Q1 FY14 and Q1 FY15: 6 months less the 3 months printed beside them.
EPS, diluted: 14 periods, Q1 FY14 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY14: share-days: the 6-month average less the second quarter's. 7 periods, Q4 FY14 to Q4 FY24: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. 4 periods, Q4 FY19 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY21: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Manufacturing - Metal Fabrication nearest Babcock & Wilcox Enterprises' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| BWBabcock & Wilcox Enterprises | $618.2M | n/m | 32.7× | n/m | n/m | n/m | |
| PKOHPark Ohio | $621M | 22.8× | 14.0× | 0.4× | +3% | 1.6% | |
| JBIJanus International | $607.1M | 18.5× | 16.8× | 0.7× | +0% | 3.7% | |
| CIXCompx International | $445.4M | 20.2× | 14.9× | 2.8× | +6% | 13.6% | |
| NXQuanex Building Products CORP | $916.5M | 20.2× | 14.7× | 0.5× | +1% | 2.4% | |
| NWPXNWPX Infrastructure | $937.9M | 19.5× | 15.1× | 1.6× | +15% | 8.5% | |
| XPELXPEL | $1.2B | 21.9× | 29.9× | 2.3× | +13% | 10.8% | |
| HLMNHillman Solutions | $1.4B | 32.7× | 82.5× | 0.9× | +6% | 2.6% | |
| TGTredegar | $255.4M | 7.6× | 11.1× | n/m | n/m | n/m | |
| OFLXOmega Flex | $249.3M | 20.8× | 40.5× | 2.6× | −4% | 12.3% | |
| ACUAcme United | $243.4M | 26.7× | 16.0× | 1.2× | +9% | 4.6% | |
| Peer median | $614.1M | 20.5× | 15.5× | 1.2× | +6% | 4.6% |
Investors who own it
Investors we follow who held Babcock & Wilcox Enterprises at the end of Jun 30, 2026, from their 13F filings.
- Polen CapitalPolen Capital0.0% of portfoliotrimmed
More on Babcock & Wilcox Enterprises
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Manufacturing - Metal Fabrication
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .